Overview of Prontopyrin plus
| Property | Description |
|---|---|
| Active ingredient | Acetaminophen, Caffeine |
| Form | Oral solid dosage (Tablets) |
| Pharmacological class | Combination Analgesic, CNS Stimulant |
| General purpose | Symptomatic relief of pain and fever |
| Origin | Synthetic |
Definition and Pharmacological Classification
Prontopyrin plus is defined as a Fixed-dose combination product, classified pharmacologically as a Combination analgesic and, due to its adjuvant component, a Central Nervous System (CNS) stimulant. This preparation is generally available as an Over-the-counter (OTC) product. The formulation integrates an established pain reliever with a stimulant, a combination supported by clinical evidence for providing enhanced pain relief for conditions such as tension headache compared to using the analgesic alone.
Active Ingredients and Compositional Features
The core composition includes the well-established analgesic Acetaminophen (Paracetamol) and the adjuvant Caffeine, both substances being of synthetic origin for pharmaceutical manufacturing. Prontopyrin plus is supplied as an Oral solid dosage form, such as Tablets, intended for the oral route of administration. This specific two-ingredient formulation is common across the pharmaceutical industry. The synergistic formulation is a differentiating factor, as the Caffeine component, a methylxanthine derivative, is included to specifically boost the effectiveness of the primary pain reliever.
General Therapeutic Purpose and Positioning
The general therapeutic purpose of this preparation is to deliver Symptomatic relief for overall discomfort associated with episodes of mild to moderate pain and fever. It is often positioned for patients seeking both effective analgesic action and a mitigating effect on the fatigue frequently accompanying symptoms like headache. The product allows the user to manage general physical discomfort and fever effectively, based on the established roles of its active ingredients.
